pyrimidine has been researched along with cyclopentane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björsne, M; Classon, B; Samuelsson, B; Szabó, T | 1 |
| Dong, Q; Fan, J; Feng, J; Gong, A; Liu, Z; Luan, T; Qu, J; Sun, P; Tu, W; Xu, G; Yang, F; Yuan, J; Zhang, H; Zhang, L | 1 |
| Aware, V; B-Rao, C; Bose, J; Chavan, S; Damre, A; Dixit, N; Gaikwad, N; Khanna, S; Manohar, S; Patil, S; Roychowdhury, A; Sharma, R; Singh, KS | 1 |
3 other study(ies) available for pyrimidine and cyclopentane
| Article | Year |
|---|---|
Synthesis and conformational analysis of pyrimidine nucleoside analogues with a rigid sugar moiety.
Topics: Antiviral Agents; Chromatography; Cyclopentanes; Cytidine; HIV-1; Humans; Magnetic Resonance Spectroscopy; Molecular Conformation; Pyrimidines; Reverse Transcriptase Inhibitors; Software; Structure-Activity Relationship | 1995 |
Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists.
Topics: Administration, Oral; Animals; Cyclopentanes; Dogs; Dose-Response Relationship, Drug; Humans; Molecular Structure; Platelet Aggregation; Platelet-Rich Plasma; Purinergic P2Y Receptor Antagonists; Pyrimidines; Rats; Receptors, Purinergic P2Y12; Structure-Activity Relationship; Triazoles | 2014 |
Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; Structure-Activity Relationship | 2015 |